-
Bi Jingquan: Biomedicine is one of the fields with the highest scientific and technological content and the most active investment
Time of Update: 2022-11-15
Bijing QuanBijing QuanDeputy Director of the Economic Committee of the National Committee of the Chinese People's Political Consultative ConferenceExecutive Vice Chairman of China Center for Internat
-
NSAIDs have been linked to heart failure in patients with diabetes
Time of Update: 2022-09-26
The study investigated the relationship between short-term NSAID use and the risk of hospitalization for first-time heart failure in the national cohort of patients with type 2 diabetes.
-
Zhu Ning returns to GSK China
Time of Update: 2021-06-11
At 5 o'clock yesterday, GSK China announced that Zhu Ning will serve as vice president, head of market access and commercial operations, effective from June 15th, and a member of the leadership team of GSK China's prescription drugs and vaccines department, based in Shanghai.
-
Practicing pharmacists equipped with the latest rules released! Implementation from next year (full text attached
Time of Update: 2021-01-07
On November 24th, the State Drug Administration officially issued a "Notice on regulating the use of practicing pharmacists in pharmaceutical retail enterprises" (hereinafter referred to as the Notice
-
Approved clinical trial of tpn171, a new class 1.1 anti pulmonary hypertension drug from Shanghai Institute of Medicine
Time of Update: 2016-03-24
It is learned from Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences that tpn171 and its tablets, a new drug for the treatment of pulmonary hypertension (PAH) 1.1, independent
-
Transfer of Sanofi rhinitis allergy drug to OTC, or impact on conbine
Time of Update: 2013-08-02
Source: great wisdom aastocks news agency 2013-8-2, the US Food and drug administration ruled on Wednesday that Sanofi's anti allergy drug Triamcinolone Acetonide Nasal Spray (Nasacort AQ) can be iden